These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25666905)

  • 1. Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.
    Gajra A; Klepin HD; Feng T; Tew WP; Mohile SG; Owusu C; Gross CP; Lichtman SM; Wildes TM; Chapman AE; Dotan E; Katheria V; Zavala L; Akiba C; Hurria A;
    J Geriatr Oncol; 2015 Mar; 6(2):133-40. PubMed ID: 25666905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy Primary Dose Reduction in Older Cancer Patients: A Retrospective Cohort.
    Bouleftour W; Tinquaut F; Lafaie L
    Cancer Invest; 2024 May; 42(5):416-424. PubMed ID: 38785096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Chemotherapy-Related Toxicity and Adverse Events in Elderly Thai Cancer Patients: A Prospective Study.
    Phaibulvatanapong E; Srinonprasert V; Ithimakin S
    Oncology; 2018; 94(3):149-160. PubMed ID: 29212082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study.
    Ostwal V; Ramaswamy A; Bhargava P; Hatkhambkar T; Swami R; Rastogi S; Mandavkar S; Ghosh J; Bajpai J; Gulia S; Srinivas S; Rath S; Gupta S
    BMJ Open; 2021 Jun; 11(6):e047376. PubMed ID: 34187825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.
    Mariano C; Jamal R; Bains P; Hejazi S; Chao L; Wan J; Ho J
    Curr Oncol; 2019 Aug; 26(4):234-239. PubMed ID: 31548802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
    Kim JW; Lee YG; Hwang IG; Song HS; Koh SJ; Ko YH; Shin SH; Woo IS; Hong S; Kim TY; Kim SY; Nam BH; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Bae SH; Koo DH; Kim KI; Kim JH
    Br J Cancer; 2018 May; 118(9):1169-1175. PubMed ID: 29576622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer.
    Won E; Hurria A; Feng T; Mohile S; Owusu C; Klepin HD; Gross CP; Lichtman SM; Gajra A; Tew WP;
    Int J Gynecol Cancer; 2013 Jul; 23(6):1022-8. PubMed ID: 23765208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study.
    Extermann M; Reich RR; Sehovic M
    Cancer; 2015 Sep; 121(17):2984-92. PubMed ID: 26033177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.
    Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
    J Geriatr Oncol; 2014 Apr; 5(2):179-84. PubMed ID: 24495700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus intravenous fluoropyrimidines for colorectal cancer.
    Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a randomised controlled trial on impact of comprehensive geriatric and supportive assessment versus standard care in older adults with cancer undergoing curative treatment: The Geriatric Oncology SuPportive clinic for ELderly (GOSPEL) study.
    Goh WY; Neo HY; Teo HL; Koh MYH; Griva K; Lim MY; Ho FCH; Hum AYM
    J Geriatr Oncol; 2023 Jan; 14(1):101342. PubMed ID: 35843845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.
    Aapro MS; Cameron DA; Pettengell R; Bohlius J; Crawford J; Ellis M; Kearney N; Lyman GH; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
    Eur J Cancer; 2006 Oct; 42(15):2433-53. PubMed ID: 16750358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Prediction Model to Assess Risk for Chemotherapy-Related Hospitalization in Patients Initiating Palliative Chemotherapy.
    Brooks GA; Kansagra AJ; Rao SR; Weitzman JI; Linden EA; Jacobson JO
    JAMA Oncol; 2015 Jul; 1(4):441-7. PubMed ID: 26181251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer.
    Wildes TM; Ruwe AP; Fournier C; Gao F; Carson KR; Piccirillo JF; Tan B; Colditz GA
    J Geriatr Oncol; 2013 Jul; 4(3):227-34. PubMed ID: 23795224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis.
    Hamid M; Hannan M; Myo Oo N; Lynch P; Walsh DJ; Matthews T; Madden S; O'Connor M; Calvert P; Horgan AM
    Curr Oncol; 2022 Aug; 29(9):6167-6176. PubMed ID: 36135053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
    Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
    Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.
    Prigerson HG; Bao Y; Shah MA; Paulk ME; LeBlanc TW; Schneider BJ; Garrido MM; Reid MC; Berlin DA; Adelson KB; Neugut AI; Maciejewski PK
    JAMA Oncol; 2015 Sep; 1(6):778-84. PubMed ID: 26203912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.